60963-18-0

Upstream product

• 60962-92-7 1,3-dichloro-2-(4-methoxyphenoxy)-5-nitrobenzene 
• 150-76-5 4-methoxy-phenol 
• 20098-48-0 3,4,5-trichloronitrobenzen 
• 3107-19-5 3,5-dichloro-4-fluoro-nitrobenzene 
• 62778-19-2 1,3-dichloro-2-iodo-5-nitrobenzene 

Downstream Products

• 355377-58-1 3,5-dichloro-4-(4-methoxy-phenoxy)-benzonitrile 
• 60962-60-9 1-[3,5-Dichloro-4-(4-methoxy-phenoxy)-phenyl]-3-((E)-3-ethoxy-acryloyl)-urea 
• 367953-34-2 3,5-dichloro-4-(4-methoxy-phenoxy)-benzaldehyde 
• 1028688-05-2 [3,5-dichloro-4-(4-methoxy-phenoxy)-phenylamino]-acetic acid ethyl ester 
• 290351-11-0 4-(4-amino-2,6-dichlorophenoxy)phenol 

Relevant academic research and scientific papers

SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS

The application relates to a compound of Formula (I') or (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I') or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.

Compound as well as synthesis method and application thereof

The invention provides a compound. The compound is characterized by comprising a structure shown in the description. The novel small-molecule compound can be used for promoting regrowth of hair when applied for external use, and can be used for treating a

SELECTIVE TR-BETA 1 AGONIST

The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta(TR-Beta). Further, the present invention relates to processes of preparing such c

SELECTIVE TR-BETA 1 AGONIST

The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta(TR-Beta). Further, the present invention relates to processes of preparing such c

Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor β (TR-β) selective ligands

Design and synthesis of a novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives are reported and their in vitro thyroid hormone receptor selectivity has been evaluated in the thyroid luciferase receptor assay. The 3-[3,5-dichloro-4-(4-hydroxy-3-isopropylph